(Q42436711)

English

Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates

scientific article published on April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 October 2017

Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates (English)

1 reference

Europe PubMed Central

31 October 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Mach RH

1

1 reference

Europe PubMed Central

31 October 2017

Voytko ML

2

1 reference

Europe PubMed Central

31 October 2017

Ehrenkaufer RL

3

1 reference

Europe PubMed Central

31 October 2017

Nader MA

4

1 reference

Europe PubMed Central

31 October 2017

Tobin JR

5

1 reference

Europe PubMed Central

31 October 2017

Efange SM

6

1 reference

Europe PubMed Central

31 October 2017

Parsons SM

7

1 reference

Europe PubMed Central

31 October 2017

Gage HD

8

1 reference

Europe PubMed Central

31 October 2017

Smith CR

9

1 reference

Europe PubMed Central

31 October 2017

Morton TE

10

1 reference

Europe PubMed Central

31 October 2017

publication date

1 April 1997

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

25

1 reference

Europe PubMed Central

31 October 2017

4

1 reference

Europe PubMed Central

31 October 2017

368-380

1 reference

Europe PubMed Central

31 October 2017

[3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Cortical GABAB and GABAA receptors in Alzheimer's disease: a quantitative autoradiographic study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Memory and cognitive function in man: Does the cholinergic system have a specific role?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Human memory and the cholinergic system. A relationship to aging?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

p-[18F]fluorobenzyltrozamicol ([18F]FBT): molecular decomposition- reconstitution approach to vesamicol receptor radioligands for positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

[3H]vesamicol binding in human brain cholinergic deficiency disorders.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Cholinergic-dopaminergic interactions in cognitive performance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

The use of [18F]4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis: Model alkylation studies and its application in the design of dopamine D1 and D2 receptor-based imaging agents

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Characterization and autoradiographic distribution of hemicholinium-3 high-affinity choline uptake sites in mammalian brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Influx of a choline analog to dog brain measured by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Human brain dopamine receptors in children and aging adults.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Laminar alterations in gamma-aminobutyric acidA, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Positron emission tomographic studies of central cholinergic nerve terminals

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Ibogaine possesses a selective affinity for sigma 2 receptors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Autoradiographic distribution of [3H]hemicholinium-3 binding sites in human brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Accurate three-dimensional registration of CT, PET, and/or MR images of the brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Selective cortical decrease of high-affinity choline uptake carrier in Alzheimer's disease: an autoradiographic study using 3H-hemicholinium-3

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

An improved method for the synthesis of radiolabeled McN5652 via thioester precursors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199704%2925%3A4%3C368%3A%3AAID-SYN8%3E3.0.CO%3B2-8

21 January 2018

Identifiers

10.1002/(SICI)1098-2396(199704)25:4<368::AID-SYN8>3.0.CO;2-8

1 reference

Europe PubMed Central

31 October 2017

release_xsq7ns7bdvdtdbxy7yonmqwg7i

1 reference

https://api.fatcat.wiki/v0/release/xsq7ns7bdvdtdbxy7yonmqwg7i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42436711&oldid=1944912572"